Biotech · Private company
Cerus Corporation
Track this companyFree. Adds Cerus Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials123 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- ControlPhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Conventional (Control)Phase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- INTERCEPTPhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- INTERCEPT Blood System for Red Blood CellsPhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- ~30 mL of INTERCEPT RBCs plus plus 10 mL biotinylated INTERCEPT RBCsPhase 2 · Transfusion Reaction, HemolyticClinicalTrials.gov · fetched Nov 12, 2026
- 30-40 mL of INTERCEPT RBCsPhase 2 · Transfusion Reaction, HemolyticClinicalTrials.gov · fetched Nov 12, 2026
- Infusion of autologous radiolabeled RBCsPhase 2 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- INTERCEPT Blood System for Platelets with LED IlluminatorPhase 2 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- INTERCEPT Blood System for RBCsPhase 2 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- INTERCEPT Treated PlateletsPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- INTERCEPT PlasmaPhase 1 · Acute Ebola Virus DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Pathogen Reduced Cryoprecipitated Fibrinogen ComplexHypofibrinogenemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCsPHASE2 · NOT_YET_RECRUITING · started Oct 10, 2026ClinicalTrials.gov NCT07152379 · fetched Nov 12, 2026
- Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated HemorrhageENROLLING_BY_INVITATION · started Sep 15, 2026ClinicalTrials.gov NCT07218185 · fetched Nov 12, 2026
- A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1PHASE2 · RECRUITING · started Sep 19, 2025ClinicalTrials.gov NCT07015437 · fetched Nov 12, 2026
- A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.PHASE2 · COMPLETED · started Jan 23, 2025ClinicalTrials.gov NCT06697223 · fetched Nov 12, 2026
- Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative BleedingPHASE4 · COMPLETED · started Apr 1, 2023ClinicalTrials.gov NCT05711524 · fetched Nov 12, 2026
- Plasma Resuscitation Without Lung InjuryPHASE4 · TERMINATED · started Aug 17, 2022ClinicalTrials.gov NCT04681638 · fetched Nov 12, 2026
- Biotin-RBC Transfusion in SCDPHASE1 · COMPLETED · started Oct 29, 2021ClinicalTrials.gov NCT04426591 · fetched Nov 12, 2026
- In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 DaysPHASE2 · COMPLETED · started Nov 5, 2019ClinicalTrials.gov NCT04022889 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery PatientsPHASE3 · COMPLETED · started Dec 5, 2018ClinicalTrials.gov NCT03459287 · fetched Nov 12, 2026
- INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsPHASE3 · COMPLETED · started May 10, 2017ClinicalTrials.gov NCT03037164 · fetched Nov 12, 2026
- A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet ComponentsCOMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02549222 · fetched Nov 12, 2026
- A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus DiseasePHASE1 · TERMINATED · started Dec 1, 2014ClinicalTrials.gov NCT02295501 · fetched Nov 12, 2026